| Literature DB >> 26643499 |
R Haussmann1, M Bauer2, M Donix2.
Abstract
Psychotic symptoms in Parkinson's disease are frequent phenomena and are often associated with an immense burden for caregivers, increased risk of nursing home placement and mortality. Treatment of psychotic disorders associated with Parkinson's disease often poses a therapeutic dilemma and necessitates a differentiated risk-benefit assessment as both the reduction of antiparkinsonian drugs and use of antipsychotic drugs can result in deterioration of motor functions. This article gives an overview of relevant clinical aspects and highlights the pharmacological evidence-based treatment options.Entities:
Keywords: Parkinson’s disease; Pharmacotherapy; Psychotic disorders; Substance-induced psychoses; Treatment
Mesh:
Substances:
Year: 2016 PMID: 26643499 DOI: 10.1007/s00115-015-4438-y
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214